MBL Infrastructure Ltd

Size: px
Start display at page:

Download "MBL Infrastructure Ltd"

Transcription

1 Q4FY11 First Cut Enhancing investment decisions

2 Explanation of CRISIL Fundamental and Valuation (CFV) matrix The CFV Matrix (CRISIL Fundamental and Valuation Matrix) addresses the two important analysis of an investment making process Analysis of Fundamentals (addressed through Fundamental Grade) and Analysis of Returns (Valuation Grade) The fundamental grade is assigned on a five-point scale from grade 5 (indicating Excellent fundamentals) to grade 1 (Poor fundamentals) The valuation grade is assigned on a five-point scale from grade 5 (indicating strong upside from the current market price (CMP)) to grade 1 (strong downside from the CMP). CRISIL Fundamental Grade Assessment CRISIL Valuation Grade Assessment 5/5 Excellent fundamentals 5/5 Strong upside (>25% from CMP) 4/5 Superior fundamentals 4/5 Upside (1-25% from CMP) 3/5 Good fundamentals 3/5 Align (+-1% from CMP) 2/5 Moderate fundamentals 2/5 Downside (- 1-25% from CMP) 1/5 Poor fundamentals 1/5 Strong downside (<-25% from CMP) Analyst Disclosure Each member of the team involved in the preparation of the grading report, hereby affirms that there exists no conflict of interest that can bias the grading recommendation of the company. Disclaimer: This Company-commissioned Report (Report) is based on data publicly available or from sources considered reliable by CRISIL (Data). However, CRISIL does not guarantee the accuracy, adequacy or completeness of the Data / Report and is not responsible for any errors or omissions or for the results obtained from the use of Data / Report. The Data / Report are subject to change without any prior notice. Opinions expressed herein are our current opinions as on the date of this Report. Nothing in this Report constitutes investment, legal, accounting or tax advice or any solicitation, whatsoever. The Report is not a recommendation to buy / sell or hold any securities of the Company. CRISIL especially states that it has no financial liability, whatsoever, to the subscribers / users of this Report. This Report is for the personal information only of the authorized recipient in India only. This Report should not be reproduced or redistributed or communicated directly or indirectly in any form to any other person especially outside India or published or copied in whole or in part, for any purpose.

3 Q4FY11 first cut Timely execution; sluggish order intake Fundamental Grade Valuation Grade Industry 3/5 (Good fundamentals) 5/5 (CMP has strong upside) Construction & Engineering MBL Infrastructure Ltd s (MBL s) Q4FY11 revenue and earnings were above CRISIL Equities expectations due to timely execution of projects. However, EBITDA margins declined by 23 bps y-o-y to 1.6% due to higher material and sub-contracting expenses. Further, its order intake during the year remained sluggish. We maintain our fundamental grade of 3/5. Q4FY11 result analysis MBL s Q4FY11 revenues registered robust growth of 81.8% y-o-y to Rs 3,855 mn given the timely execution of projects. For FY11, revenue grew by 57.2% y-o-y to Rs 1 bn. EBITDA margin declined by 23 bps y-o-y to 1.6% on the back of increased raw material and sub-contracting expenses. However, for FY11, EBITDA margin declined only by 65 bps 13.7% y-o-y. PAT increased 24.8% y-o-y to Rs 151 mn due to robust growth in revenue. However, PAT margin declined by 179 bps y-o-y to 3.9% given the higher interest expenses and tax outgo. For FY11, PAT increased by 66.9% to Rs 617 mn and PAT margin increased 36 bps to 6.2%. The company did not receive any new orders during the reported quarter. Valuations: Current market price has strong upside We continue to value MBL on sum-of-the-parts method. We have assigned a multiple of 7x to the FY12 contracting business with EPS of Rs 38 and valued the BOT business on DCF basis with Rs 2 per share, which gives a fair value of Rs 286 per share. Based on the current market price, our valuation grade is 5/5. KEY FORECAST (Rs mn) FY8 FY9 FY1 FY11# FY12E Operating income 2,945 5,143 6,377 1,16 9,223 EBITDA ,371 1,462 Adj PAT Adj EPS-Rs EPS growth (%) (32.6) Dividend yield RoCE(%) RoE(%) PE (x) P/BV (x) EV/EBITDA (x) NM: Not meaningful; CMP: Current Market Price #FY11 numbers based on the abridged financials estimate May 3, 211 Fair Value Rs 286 CMP Rs 155 CFV MATRIX KEY STOCK STATISTICS NIFTY / SENSEX 5473/18232 NSE / BSE ticker MBLINFRA Face value (Rs per share) 1 Shares outstanding (mn) 17.5 Market cap (Rs mn)/(us$ mn) 2,715/6 Enterprise value (Rs mn) /(US$ mn) 5,324/ week range (Rs) (H/L) 293/138 Beta.67 Free float (%) 43% Avg daily volumes (3-days) 5,351 Avg daily value (3-days) (Rs mn) 2.5 SHAREHOLDING PATTERN 1% 9% 8% 7% 6% 5% 4% 3% 2% 1% Excellent Fundamentals Fundamental Grade Poor Fundamentals % Strong Downside Valuation Grade 24.8% 24.% 25.8% 25.3% 13.% 12.7% 12.6% 13.2% 4.8% 6.% 4.3% 4.3% 57.3% 57.3% 57.3% 57.3% PERFORMANCE VIS-À-VIS MARKET Returns Strong Upside Jun-1 Sep-1 Dec-1 Mar-11 Promoter FII DII Others 1-m 3-m 6-m 12-m MBL -21% -17% -1% -26% NIFTY -6% 3% -5% 9% ANALYTICAL CONTACT Sudhir Nair (Head) Sandeep Panchal Bhaskar Bukrediwala snair@crisil.com sapanchal@crisil.com bsbukrediwala@crisil.com Client servicing desk clientservicing@crisil.com CRISIL EQUITIES 1

4 Q4FY11 Result Summary (Rs mn) Q4FY11 Q3FY11 Q4FY1 q-o-q (%) y-o-y (%) FY11 FY1 y-o-y (%) Net sales 3,855 2,677 2, ,16 6, Materials and Sub Contract cost 3,284 2,136 1, ,132 5, % of net sales 85.2% 79.8% 8.% 543bps 523bps 81.19% 8.3% 93bps Employees cost Other expenses EBITDA (2.8) , EBITDA margin 1.6% 15.8% 12.9% -512bps -23bps 13.7% 14.3% -65bps Depreciation (1.6) EBIT (2.8) , Interest and finance charges (.6) Operating PBT (3.6) Other Income (2.9) PBT (3.2) Tax PAT (34.7) Adj PAT (34.7) Adj PAT margin 3.9% 8.6% 5.7% -471bps -179bps 6.2% 5.8% 36bps No of equity shares (Mn) (.) Adj EPS (Rs) (34.7) Revenue growth intact, EBITDA margin declined Quarterly PAT and PAT margins (Rs mn) (Rs mn) 4,5 4, 3,5 3, 2,5 2, 1,5 1, % 15.% 15.3% 15.8% 14.5% 14.8% 12.9% 1.6% 1,59 1,97 1,643 2,121 2,254 1,23 2, % 16% 14% 12% 1% 8% 6% 4% 2% % % 5.2% 8.6% 7.% 5.7% 6.4% 6.4% 3.9% % 9% 8% 7% 6% 5% 4% 3% 2% 1% % Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Dec-1 Mar-11 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Dec-1 Mar-11 Revenue EBITDA margin (RHS) PAT PAT margin (RHS) Share price movement vs. NIFTY Fair value movement since initiation (Rs) (') Jan-1 28-Feb-1 17-Apr-1 4-Jun-1 22-Jul-1 8-Sep-1 26-Oct-1 13-Dec-1 3-Jan Mar-11 6-May-11 2-Jun-1 21-Jun-1 8-Jul-1 27-Jul-1 13-Aug-1 1-Sep-1 21-Sep-1 8-Oct-1 27-Oct-1 15-Nov-1 3-Dec-1 23-Dec-1 11-Jan Jan Feb-11 9-Mar Mar Apr-11 6-May May-11 MBL NIFTY -indexed to 1 Traded Quantity (RHS) CRISIL Fair Value MBL Source: NSE, CRISIL Equities CRISIL EQUITIES 2

5 FINANCIALS Income statement Balance Sheet (Rs mn) FY9 FY1 FY11# (Rs mn) FY9 FY1 FY11# Operating income 5,143 6,377 1,16 Liabilities EBITDA ,371 Equity share capital EBITDA margin 14.5% 14.4% 13.7% Reserves 864 2,66 2,632 Depreciation Minorities EBIT ,275 Net worth 982 2,241 2,87 Interest Convertible debt Operating PBT Other debt 1,57 1,689 2,99 Other income Total debt 1,57 1,689 2,99 Exceptional inc/(exp) 1 (96) - Deferred tax liability (net) PBT Total liabilities 2,639 4,75 5,924 Tax provision Assets Minority interest Net fixed assets 1,245 1,45 1,658 PAT (Reported) Capital WIP Less: Exceptionals 1 (96) - Total fixed assets 1,245 1,498 1,658 Adjusted PAT Investments - - Current assets Ratios Inventory ,942 FY9 FY1 FY11# Sundry debtors 1,2 2,213 2,464 Growth Loans and advances Operating income (%) Cash & bank balance EBITDA (%) Marketable securities Adj PAT (%) Total current assets 2,695 4,342 5,49 Adj EPS (%) 51.3 (8.7) 66.9 Total current liabilities 1,31 1,766 1,143 Net current assets 1,394 2,576 4,266 Profitability Intangibles/Misc. expenditure EBITDA margin (%) Total assets 2,639 4,75 5,924 Adj PAT Margin (%) RoE (%) Cash flow RoCE (%) (Rs mn) FY9 FY1 FY11# RoIC (%) Pre-tax profit Total tax paid (74) (123) (243) Valuations Depreciation Price-earnings (x) Working capital changes (834) (1,297) (1,727) Price-book (x) Net cash from operations (443) (82) (951) EV/EBITDA (x) Cash from investments EV/Sales (x) Capital expenditure (196) (32) (255) Dividend payout ratio (%) Investments and others - - () Dividend yield (%) Net cash from investments (196) (32) (255) Cash from financing B/S ratios Equity raised/(repaid) (1,28) Inventory days Debt raised/(repaid) ,22 Creditors days Dividend (incl. tax) (27) (41) (48) Debtor days Others (incl extraordinaries) (149) - 1,25 Working capital days Net cash from financing 818 1,7 1,169 Gross asset turnover (x) Change in cash position 178 (115) (37) Net asset turnover (x) Closing cash Sales/operating assets (x) Current ratio (x) Quarterly financials Debt-equity (x) (Rs mn) Q4FY1 Q1FY11 Q2FY11 Q3FY11 Q4FY11 Net debt/equity (x) Net Sales 2,121 2,254 1,23 2,677 3,855 Interest coverage Change (q-o-q) 29% 6% -45% 118% 44% EBITDA Per share Change (q-o-q) 15% 22% -38% 15% -3% FY9 FY1 FY11# EBITDA margin 12.9% 14.8% 16.7% 15.8% 1.6% Adj EPS (Rs) PAT CEPS Adj PAT Book value C hange (q-o-q) 15% 3% -5% 194% -35% Dividend (Rs) Adj PAT margin 5.7% 7.% 6.4% 8.6% 3.9% Actual o/s shares (mn) Adj EPS #FY11 numbers based on the abridged financials estimate CRISIL EQUITIES 3

6 CRISIL Independent Equity Research Team Mukesh Agarwal Senior Director +91 (22) Tarun Bhatia Director, Capital Markets +91 (22) Chetan Majithia Head, Equities +91 (22) Sudhir Nair Head, Equities +91 (22) Prasad Koparkar Head, Research +91 (22) Ajay D'Souza Head, Research +91 (22) Aparna Joshi Head, Research +91 (22) Manoj Mohta Head, Research +91 (22) Sridhar C Head, Research +91 (22) sridharc@crisil.com CRISIL s Equity Offerings The Equity Group at CRISIL Research provides a wide range of services including: Independent Equity Research IPO Grading White Labelled Research Valuation on companies for use of Institutional Investors, Asset Managers, Corporate Other Services by the Research group include CRISINFAC Industry research on over 6 industries and Economic Analysis Customised Research on Market sizing, Demand modelling and Entry strategies Customised research content for Information Memorandum and Offer documents

7 About CRISIL CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations. About CRISIL Research CRISIL Research is the country s largest independent and integrated research house with strong domain expertise on Indian economy, industries and capital markets. We leverage our unique research platform and capabilities to deliver superior perspectives and insights to over 12 domestic and global clients, through a range of research reports, analytical tools, subscription products and customised solutions To know more about CRISIL IER, please contact our team members: Vinaya Dongre Head, Business Development vdongre@crisil.com I Phone : Ashish Sethi Head, Business Development asethi@crisil.com I Phone : Sagar Sawarkar Senior Manager, Business Development ssawarkar@crisil.com I Phone : Regional Contacts: Ahmedabad / Mumbai / Pune Vishal Shah - Manager, Business Development vishah@crisil.com I Phone : Bengaluru / Chennai Anand Krishnamoorthy - Manager, Business Development ankrishnamoorthy@crisil.com I Phone : Hyderabad Kaliprasad Ponnuru - Manager, Business Development kponnuru@crisil.com I Phone : Kolkata / Delhi Priyanka Agarwal - Manager, Business Development priyagarwal@crisil.com I Phone : Head Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai Phone : Web: Download reports from:

CRISIL IER Independent Equity Research

CRISIL IER Independent Equity Research CRISIL IER Independent Equity Research Bhartiya International Ltd Q3FY14 Results Update Enhancing investment decisions CRISIL IER Independent Equity Research Explanation of CRISIL Fundamental and Valuation

More information

FY08 FY09 FY10 FY11E FY12E FY13E FY14E FY15E

FY08 FY09 FY10 FY11E FY12E FY13E FY14E FY15E XYZ Company Limited Date Valuation Report: DUMMY Executive Summary INDUSTRY: XX XYZ Company Limited (hereinafter referred to as XYZ or the company ) is a XX manufacturing company and markets its products

More information

CRISIL IERIndependentEquityResearch

CRISIL IERIndependentEquityResearch MAKING MARKETS FUNCTION BETTER YEARS CRISIL IERIndependentEquityResearch Ashiana Housing Ltd Apollo Hospitals Enterprise Ltd Detailed Report Q1FY13 Results Update Enhancing investment decisions CRISIL

More information

Mangalam Cement Weak volumes marred performance

Mangalam Cement Weak volumes marred performance CMP* (Rs) 206 Market Cap. (Rs bn) 5.5 Free Float (%) 72 Shares O/S (mn) 26.7 Mangalam Cement Weak volumes marred performance Mangalam Cement (MCL) delivered a weak performance in 2Q but was marginally

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 SPS Finquest Ltd CMP: 84.60 January 13, 2015 Stock Details BSE code 538402 BSE ID SPS Face value ( ) 10 No of shares

More information

Flexituff International Ltd. (FIL)

Flexituff International Ltd. (FIL) s $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 (Wholly owned subsidiary of Bank of Baroda) Q2FY16 Result Review BUY Flexituff International Ltd. (FIL)

More information

Gujarat State Petronet Ltd. INR 135

Gujarat State Petronet Ltd. INR 135 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Oil & Gas RESULT UPDATE Gujarat State Petronet Ltd. INR 135 Growth in volumes to propel earnings Accumulate Gujarat

More information

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015 17-Nov-14 17-Dec-14 17-Jan-15 17-Feb-15 17-Mar-15 17-Apr-15 17-May-15 17-Jun-15 17-Jul-15 17-Aug-15 17-Sep-15 17-Oct-15 Coal India Ltd. Subdued e-auction realization impacted profitability Coal India Ltd.

More information

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI $Com panyname$ Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) HOLD PI Industries Ltd. Custom synthesis

More information

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH Q2FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH SUPREME INDUSTRIES LTD Plastic Products BSE CODE:509930 NSE CODE: SUPREMEIND Bloomberg CODE: SIL IN SENSEX: 24,470 HOLD CMP Rs725

More information

Tree House Education & Accessories

Tree House Education & Accessories 2QFY2016 Result Update Educational Services November 10, 2015 Tree House Education & Accessories Performance Highlights Y/E March (` cr) 2QFY16 2QFY15 % chg (qoq) 1QFY16 % chg (yoy) Net sales 57 50 15.1

More information

Bata India Ltd. (BIL)

Bata India Ltd. (BIL) Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Q2FY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Bata India Ltd. (BIL) Cloudy quarter sunshine ahead;

More information

Smruthi Organics Limited BSE Scrip Code: 590046

Smruthi Organics Limited BSE Scrip Code: 590046 Smruthi Organics Limited BSE Scrip Code: 590046 Pharmaceuticals September 21, 2012 Equity Statistics Current Market Price Rs. 218.1 52 Week High / Low Rs. 273.9 / 155 Market Capitalisation Rs. crores 83.2

More information

Axis Bank. Strong core performance. Source: Company Data; PL Research

Axis Bank. Strong core performance. Source: Company Data; PL Research Strong core performance January 17, 2011 Abhijit Majumder abhijitmajumder@plindia.com +91 22 66322236 Umang Shah umangshah@plindia.com +91 22 66322242 Rating BUY Price Rs1,230 Target Price Rs1,600 Implied

More information

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance s (STFC) standalone performance was broadly in-line with our expectation but grossly disappointed on asset

More information

Strong operational performance

Strong operational performance ABB India Equity Research Engineering & Capital Goods February 8, 2016 Result Update Emkay Your success is our success Strong operational performance CMP Target Price Rs1,134 Rs1,407 ( ) Rating Upside

More information

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Salzer Electronics Ltd. Steady

More information

Khambatta Securities Ltd.

Khambatta Securities Ltd. Attractive Valuation Strong Buy Sector : Bank Private Target Price : Rs 284 Current Market Price : Rs 230 Market Cap : Rs 1,337 bn 52-week High/Low : Rs 393/216 Daily Avg. Volume : 13.88 mn Shares in issue

More information

Techno Electric & Engineering Limited

Techno Electric & Engineering Limited Engineering & Capital Goods Event Update Techno Electric & Engineering Limited Buy Wind business spin off will lead to value unlocking. Institutional Research CMP (`) 404 Target (`) 504 Nifty: 8,224 Sensex:

More information

Simplex Infrastructures

Simplex Infrastructures 2QFY216 Result Update Infrastructure November 17, 215 Simplex Infrastructures Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq) Net

More information

HCC BUY. Infrastructure January 29, 2016

HCC BUY. Infrastructure January 29, 2016 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 Dec-15 Jan-16 India Research Infrastructure January 29, 2016 QUARTERLY REVIEW Bloomberg: IN Reuters: HCNS.BO BUY Better margins drive earnings s

More information

GAIL (India) Ltd. INR 346

GAIL (India) Ltd. INR 346 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 India Equity Institutional Research Oil & Gas RESULT UPDATE GAIL (India) Ltd. INR 346 Good performance; Near term outlook looks stable BUY GAIL reported

More information

UltraTech Cement Ltd.

UltraTech Cement Ltd. Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 October 31, 212 COMPANY RESULTS REPORT REVIEW UltraTech Cement Ltd. Rich valuation overlooks strong performance

More information

Just Dial Ltd Bloomberg Code: JUST IN

Just Dial Ltd Bloomberg Code: JUST IN Communications - Internet Media Oct 14, 215 Bloomberg Code: JUST IN India Research - Stock Broking India s local search engine, warming up with add-on services Just Dial is now into a platform where people

More information

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, 2015. Target Price Rs220. IT India.

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, 2015. Target Price Rs220. IT India. CMP* (Rs) 204 Market Cap. (Rs bn) 20 Free Float (%) 71 Shares O/S (mn) 100 Polaris Virtusa acquires majority in Polaris Virtusa Corp has purchased promoter and Citi s stake in Polaris of 53% for Rs220

More information

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022 BUY CMP 226.50 Target Price 260.00 KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16 JANUARY 9 th 2015 ISIN: INE164B01022 Index Details Stock Data Sector IT Software Products BSE Code 519602

More information

Navin Fluorine International

Navin Fluorine International RESULTS REVIEW 2QFY16 29 OCT 2015 Navin Fluorine International INDUSTRY CHEMICALS CMP (as on 29 Oct 2015) Rs 1,579 Target Price Rs 1,800 Nifty 8,112 Sensex 26,838 KEY STOCK DATA Bloomberg NFIL IN No. of

More information

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH Q3FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH Exide Industries Ltd(EIL) Automobile Ancillaries BSE CODE: 500086 NSE CODE: EXIDEIND Bloomberg CODE: EXID IN SENSEX: 23,759 Accumulate

More information

GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare Strong pricing power, Attractive valuations "BUY" February 09, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs5,837

More information

East India Hotels (EIH) 114

East India Hotels (EIH) 114 Result Update Rating matrix Rating : Hold Target : 124 Target Period : 12-15 months Potential Upside : 8% What s Changed? Target Changed from 133 to 124 EPS FY16E Unchanged EPS FY17E Changed from 2.8 to

More information

RamKrishna Forgings Ltd.

RamKrishna Forgings Ltd. January 3, 2014 RamKrishna Forgings Ltd. Poised for Growth CMP INR 81 Target INR 117.2 Coverage Follow Up BUY Key Share Data Face Value (INR) 10 Equity Capital (in INR Million) 211.0 Market Cap (in INR

More information

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP 1677.00 Target Price 1880.00. SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP 1677.00 Target Price 1880.00. SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010 BUY CMP 1677.00 Target Price 1880.00 ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16 SEPTEMBER 2 nd, 2015 ISIN: INE738I01010 Index Details Stock Data Sector IT & ITes BSE Code 532927 Face

More information

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016 JSW Energy Ltd. Interest expenses dragged the bottom-line JSW Energy Ltd. (JSWEL) reported a mixed set of numbers for Q3 FY16 quarter. The company reported a consolidated total operating income of Rs.

More information

Share gains with healthy margin uptick; Retain Buy

Share gains with healthy margin uptick; Retain Buy Colgate-Palmolive India Equity Research Consumers January 23, 2015 Result Update Emkay Your success is our success Share gains with healthy margin uptick; Retain Buy CMP Target Price Rs1,913 Rs1,940 (

More information

Kalyani Steel. Q3FY16 Result Review. Operationally firming up ; maintain BUY BUY. Sector: IRON & STEEL/INTERM PRODUCTS

Kalyani Steel. Q3FY16 Result Review. Operationally firming up ; maintain BUY BUY. Sector: IRON & STEEL/INTERM PRODUCTS $Com panyname$ Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Q3FY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Kalyani Steels Ltd. Operationally

More information

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16 BUY CMP 292.20 Target Price 336.00 RSWM LTD Result Update(PARENT BASIS): Q1 FY16 SEPTEMBER 1 st 2015 ISIN: INE611A01016 Index Details Stock Data Sector Textiles BSE Code 500350 Face Value 10.00 52wk. High

More information

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights The case of missing sales growth Zydus Q3 net sales at Rs1.1 bn was up 3% on a like-to-like basis (Q3 15 had Rs 223 mn additional excise duty credit from prior periods), below our estimate of 6%. The company

More information

Higher other income drive the quarter

Higher other income drive the quarter Gujarat State Petronet India Equity Research Oil & Gas February 4, 2016 Result Update Emkay Your success is our success Higher other income drive the quarter CMP Target Price Rs136 Rs163 ( ) Rating Upside

More information

The Ramco Cements. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research Robust performance; remains the best play on Southern region February 09, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price

More information

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, 2015. CRISIL Ltd. Recommendation (Rs.)

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, 2015. CRISIL Ltd. Recommendation (Rs.) Technology - Technology Services - Information Services India Research - Stock Broking Economic recovery to boost revenues across business segments: The rating revenues witnessed 8% growth in 214 compared

More information

Results impacted by subdued demand

Results impacted by subdued demand India Equity Research Agri Input & Chemicals January 25, 2016 Result Update Coromandel International Results impacted by subdued demand Emkay Your success is our success CMP Target Price Rs165 Rs225 (

More information

East India Hotels (EIH) Ltd Growing Strategically

East India Hotels (EIH) Ltd Growing Strategically East India Hotels (EIH) Ltd Growing Strategically BSE Code 500840 NSE Code EIHOTEL Bloomberg Code EIH@IN Face Value 10 CMP Rs 224 Market Cap Rs 11.7bn (as on August 27th 2004) Share Holding Pattern Others

More information

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights 05 FEB 2016 Quarterly Update BUY Target Price: Rs 344 Muted Q3; Brands & Retail story to unfold Arvind s Q3 consolidated revenue at Rs 21.6 bn (Rs 20.7 bn in Q3FY15) was marginally below our estimate of

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 196.40 Target Price 225.00 STYLAM INDUSTRIES LIMITED Result Update (PARENT BASIS): Q2 FY16 DECEMBER 16 th. 2015 ISIN: INE239C01012 12 th h, 2013 Index Details Stock Data Sector Plastic Products

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 170.30 Target Price 196.00 GEOMETRIC LTD Result Update (CONSOLIDATED): Q2 FY16 DECEMBER 17 th 2015 ISIN: INE797A01021 12 th h, 2013 Index Details Stock Data Sector IT Consulting & Software BSE

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Q3 results subdued, Outlook remains good; BUY January 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs4,103 Target Price Rs4,844 Implied Upside 18.1% Sensex 24,470 Nifty

More information

East India Hotels (EIH) 109

East India Hotels (EIH) 109 Result Update Rating matrix Rating : Hold Target : 1 Target Period : 12-15 months Potential Upside : -8% What s Changed? Target Changed from 124 to 1 EPS FY17E Changed from 2.3 to 2. EPS FY18E Introduced

More information

Re-iterating BUY. Destimoney Research

Re-iterating BUY. Destimoney Research NTPC Limited (NTPC) Re-iterating BUY Destimoney Research 18 July 2013 NTPC Limited BUY TARGET : `170 CMP : `146 Key Data Bloomberg Code NTPC IN NSE Code NTPC BSE Code 532555 Sector Power Industry Electric

More information

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research FY17 could be a year of revenue growth February 08, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating Accumulate Price Rs440 Target Price Rs510 Implied Upside 15.9% Sensex 24,617 Nifty

More information

Britannia Industries

Britannia Industries Rally in Input costs near term drag, Maintain BUY June 20, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs2,641

More information

Reliance Communication

Reliance Communication 3QFY214 Result Update Telecom February 11, 214 Reliance Communication Performance highlights (` cr) 3QFY14 2QFY14 % chg (qoq) 3QFY13 % chg (yoy) Net sales 5,43 5,394.2 5,31 1.9 EBITDA 1,845 1,887 (2.2)

More information

Orchid Chemicals NEUTRAL. Performance Highlights. Target Price - 1QFY2011 Result Update Pharmaceutical. Investment Period -

Orchid Chemicals NEUTRAL. Performance Highlights. Target Price - 1QFY2011 Result Update Pharmaceutical. Investment Period - 1QFY211 Result Update Pharmaceutical July 21, 21 Orchid Chemicals Performance Highlights Y/E March (Rs cr) 1QFY211 4QFY21 %chg (qoq) 1QFY21 %chg (yoy) Net Sales 34 286 6.3 36 (.7) Other Operating Income

More information

Minda Industries Ltd. INR 886

Minda Industries Ltd. INR 886 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Automobiles RESULT UPDATE Minda Industries Ltd. INR 886 Profit boosted by margins ACCUMULATE In Q3FY16, Minda Industries

More information

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 1,213 Q4 earnings beat but order backlog flat s Q4CY15revenue at Rs24bnwasin line withour expectation of Rs24bn. EBITDA margin improved 290 bps YoYand

More information

BDI BioEnergy Intern. 20.0 Neutral. Activity level in Q3 might not support FY estimates

BDI BioEnergy Intern. 20.0 Neutral. Activity level in Q3 might not support FY estimates 8/11/1 8/1/11 8/3/11 8/5/11 8/7/11 8/9/11 8/11/11 8/1/12 8/3/12 8/5/12 8/7/12 8/9/12 MATELAN Research Preview Note Price as of 9/11/12: 8.69 12 November 212 Company / Sector Fair Value Recommendation BDI

More information

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead 05 FEB 2016 Quarterly Update BUY Target Price: Rs 160 Operationally in line; other income surprises GSPL s Q3FY16PAT at Rs 1.2bn was higher than our estimate (Rs 1.1bn) due to higher other income at Rs

More information

How To Value Hpl In India

How To Value Hpl In India Materials - Containers & Packaging Oct 01, 2015 Bloomberg Code: HPPL IN India Research - Stock Broking Backed by Acquisition, Set to Augment Market Share New acquisition: In FY15, HPPL acquired 100% of

More information

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK 28 Jan 15 28 Apr 15 28 Jul 15 28 Oct 15 DUBAI ISLAMIC BANK In line performance Results update 4Q2015 Banks UAE 28 January 2016 Dubai Islamic Bank s (DIB) reported net profit of AED865mn, in-line with our

More information

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold HOLD Target price (INR) 452 Momentum in loans sustains, upgrade to Hold India Equity Research Financials January 30, 2013 Rating The higher than expected growth in the NII was driven by an improvement

More information

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins HSIL India Equity Research Others February 3, 2016 Result Update Emkay Your success is our success Revenues traction improves; Retain BUY CMP Target Price Rs271 Rs370 ( ) Rating Upside BUY ( ) 36.6 % Healthy

More information

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD Index Details SWARAJ ENGINES LTD Result Update (PARENT BASIS): Q4 FY16 Stock Data Sector Auto Parts & Equipment BSE Code 500407 Face Value 10.00 52wk. High / Low (Rs.) 1207.90/762.00 Volume (2wk. Avg.)

More information

CRISIL IERIndependentEquityResearch

CRISIL IERIndependentEquityResearch MAKING MARKETS FUNCTION BETTER YEARS CRISIL IERIndependentEquityResearch Responsive Industries Apollo Hospitals Ltd Enterprise Ltd Detailed Report Detailed Report Enhancing investment decisions CRISIL

More information

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights 25 JAN 2016 Quarterly Update BUY Target Price: Rs 155 Lower realization impacts earnings Despite flat QoQ oil and gas production, Cairn s Q3FY16 PAT slumped to Rs 87mn (vs. Rs 6,727 bn in Q2FY16) due to

More information

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 252 Q4 lackluster; CY16 holds promise Hexaware s Q4CY15 performance was lower than our estimates. Revenue growth and margin were largely impacted due

More information

Va Tech Wabag. Source: Company Data; PL Research

Va Tech Wabag. Source: Company Data; PL Research Weak execution, guidance hints a strong Q4FY16 February 08, 2016 Nishna Biyani nishnabiyani@plindia.com +91 22 66322239 Keyur Pandya keyurpandya@plindia.com +91 22 +91 22 66322247 Rating BUY Price Rs577

More information

CRISIL - AMFI ELSS Fund Performance Index. Factsheet March 2016

CRISIL - AMFI ELSS Fund Performance Index. Factsheet March 2016 CRISIL - AMFI ELSS Fund Performance Index Factsheet March 2016 Table of Contents About the Index... 3 Features and Characteristics... 3 Methodology... 3 CRISIL - AMFI ELSS Fund Performance Index: Constituent

More information

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart 1QFY2016 Result Update IT October 21, 2015 HCL Technologies Performance Highlights (` cr) Consl. 1QFY16 4QFY15 % chg (qoq) 1QFY15 % chg (yoy) Net revenue 10,097 9,777 3.3 8,735 15.6 EBIT 1,979 1,976 0.2

More information

Cipla Ltd. Rs. 741. India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

Cipla Ltd. Rs. 741. India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765 India Equity Institutional Research Pharma RESULT UPDATE Cipla Ltd. Rs. 741 One off revenues from Nexium supply drives earnings HOLD Result highlights Cipla s Q1FY16 result beats our estimates due to higher

More information

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16 RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS Earnings Presentation Q2 FY16 Company Overview COMPANY OVERVIEW Rajesh Exports Ltd. (REL) was incorporated in 1989. Currently REL is a leader

More information

Kotak Mahindra Bank Rs 685

Kotak Mahindra Bank Rs 685 India Equity Institutional Research BANKS RESULT UPDATE Kotak Mahindra Bank Rs 685 Smooth merger; benefits to accrue HOLD KMB s consolidated PAT for Q4FY15 stood at INR 9.5 that primarily on the back of

More information

Granules India Ltd. INR 113

Granules India Ltd. INR 113 India Equity Institutional Research Pharma RESULT UPDATE Granules India Ltd. INR 113 Misses expectation BUY Result highlights Net sales for the quarter grew by a moderate 8% YoY to INR 3,449mn below our

More information

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers 11 FEB 2016 Quarterly Update HOLD Target Price: Rs 377 Q3 muted; recovery ahead Astral sq3fy16 results were impacted due to: (1) adverse raw-material prices in pipe division (~Rs 80 mn), (2) closure of

More information

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788 January 3, 216 CMP* (Rs) 748 Upside/ (Downside) 5 Market Cap. (Rs bn) 314 Free Float 78 Shares O/S (mn) 419 YES Bank Not out of the woods yet; Asset quality remains a key monitorable YES Bank reported

More information

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research Strong margins, improved inflows! January 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,228 Target Price Rs1,353

More information

CRISIL - AMFI Diversified Equity Fund Performance Index. Factsheet September 2015

CRISIL - AMFI Diversified Equity Fund Performance Index. Factsheet September 2015 CRISIL - AMFI Diversified Equity Fund Performance Index Factsheet September 2015 Table of Contents About the Index... 3 Features and Characteristics... 3 Methodology... 3 CRISIL - AMFI Diversified Equity

More information

Butterfly Gandhimathi (GANAP) 188

Butterfly Gandhimathi (GANAP) 188 Result Update Rating matrix Rating : Buy Target : 240 Target Period : 12 months Potential Upside : 27% What s changed? Target EPS FY16E EPS FY17E Rating Quarterly performance Unchanged Unchanged Unchanged

More information

Bharat Earth Movers (BEML)

Bharat Earth Movers (BEML) 2QFY2016 Result Update Capital Goods November 13, 2015 Bharat Earth Movers (BEML) Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq)

More information

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015

SAIL (SAIL) 56. Dismal performance. Result Update. ICICI Securities Ltd Retail Equity Research. August 17, 2015 Result Update Rating matrix Rating : Sell Target : 50 Target Period : 12 months Potential Upside : -11% What s Changed? Target Changed from 60 to 50 EPS FY16E Changed from 4.8 to 1.1 EPS FY17E Changed

More information

CD Equisearch Pvt Ltd

CD Equisearch Pvt Ltd Dec 10, 2015 Mayur Uniquoters Ltd. No. of shares (m) 46.3 Mkt cap (Rs crs/$m) 1943/291 Current price (Rs/$) 420/6.3 Price target (Rs/$) 475/7.1 52 week H/L (Rs.) 518/378 Book Value (Rs/$) 67.8/1.0 P/BV

More information

Mahindra CIE Automotive Ltd.

Mahindra CIE Automotive Ltd. Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15. Volume No.. 1 Issue No. 9 Automotive Ltd. April 08, 2015 BSE Code: 532756 NSE Code: MAHIND Reuters Code: MAHN.NS

More information

Idea Cellular (IDECEL) 178

Idea Cellular (IDECEL) 178 Result Update Rating matrix Rating : Buy Target : 215 Target Period : 12 months Potential Upside : 24% What s changed? Target Unchanged EPS FY16E Changed from 9.3 to 10.1 EPS FY17E Changed from 6.1 to

More information

MAITHAN ALLOYS LTD Result Update (PARENT BASIS): Q4 FY16

MAITHAN ALLOYS LTD Result Update (PARENT BASIS): Q4 FY16 Index Details MAITHAN ALLOYS LTD Result Update (PARENT BASIS): Q4 FY16 Stock Data Sector Iron & Steel/Interm. Products BSE Code 590078 Face Value 10.00 52wk. High / Low (Rs.) 313.80/72.25 Volume (2wk.

More information

Jubilant Life Sciences

Jubilant Life Sciences Radiopharma, Niacin continues to drive sales, margins October 30, 2015 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs401 Target Price Rs578 Implied Upside 44.1% Sensex 26,838 Nifty

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 514.75 Target Price 590.00 DOC CODE: FOTL_090220164_3 IGARASHI MOTORS INDIA LTD Result Update (PARENT BASIS): Q3 FY16 FEBRUARY 9 th 2016 ISIN: INE188B01013 12 th h, 2013 Index Details Stock Data

More information

Aurobindo Pharma. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research Earnings in line; Strong guidance for FY17E maintained February 10, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs691 Target Price Rs943 Implied Upside 36.5% Sensex 23,759 Nifty

More information

Greenply Industries Ltd

Greenply Industries Ltd Change in Estimates Rating Target Greenply Industries Ltd Q2 FY16 Q2FY16 net revenue of Greenply Industries or GIL at Rs401cr, 2.5%/9.2% below our/bloomberg estimate of Rs411cr/Rs441cr, respectively, led

More information

India Equity Research Telecommunications September 2, 2015 Management Meet Update

India Equity Research Telecommunications September 2, 2015 Management Meet Update Bharti Infratel India Equity Research Telecommunications September 2, 2015 Management Meet Update Emkay Your success is our success Data demand to accelerate growth CMP Rs396 Target Price Rs505 ( ) Rating

More information

www.pvpglobal.com SECTOR: REALTY REPORTING DATE: 31 ST MAY, 2016 PVP Ventures Ltd

www.pvpglobal.com SECTOR: REALTY REPORTING DATE: 31 ST MAY, 2016 PVP Ventures Ltd 31 st May, 2016 TABLE 1 MARKET DATA (STANDALONE) (As on 31 st May, 2016) NSE Code PVP NSE Market Price ( ) 4.50 NSE Market Cap. ( Cr.) 118.85 Sector Realty Face Value ( ) 10.00 Equity ( Cr.) 245.05 52

More information

JLR Nov-15 wholesale up 24% YoY to 51,021 units

JLR Nov-15 wholesale up 24% YoY to 51,021 units BSE Sensex S&P CNX 25,036 7,613 9 December 2015 Update Sector: Automobiles Tata Motors CMP: INR394 TP: INR471 (+20%) Buy Stock Info Bloomberg TTMT IN Equity Shares (m) 3,395.9 M.Cap. (INR b)/(usd b) 1,338/20

More information

Private drilling fluid technology service leader

Private drilling fluid technology service leader 21 March 2012 Equity Research Report Company Research Petroleum & Petrochemical Sichuan Renzhi Oilfield Technology Services (002629) Investment value analysis report Private drilling fluid technology service

More information

Pidilite Industries. Source: Company Data; PL Research

Pidilite Industries. Source: Company Data; PL Research Bountiful margin expansion in a tepid demand scenario February 03, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate

More information

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research. Sector Update Rating matrix Target price Company Old New CMP Potential Upside HEG 225 275 238 19% Graphite India 85 15 91 18% Target period 12-15 months Price performance (%) Return % 1M 3M 6M 12M HEG

More information

HINDUSTAN COMPOSITES LTD Result Update (PARENT BASIS): Q4 FY16

HINDUSTAN COMPOSITES LTD Result Update (PARENT BASIS): Q4 FY16 HINDUSTAN COMPOSITES LTD Result Update (PARENT BASIS): Q4 FY16 Index Details Stock Data Sector Auto Parts & Equipment BSE Code 509635 Face Value 10.00 52wk. High / Low (Rs.) 1567.00/750.00 Volume (2wk.

More information

Techno Electric & Engineering Co Ltd

Techno Electric & Engineering Co Ltd ANTIQUE STOCK BROKING LIMITED 2 June 2016 1 Current Reco Previous Reco CMP Renjith Sivaram +91 22 4031 3414 renjith.sivaram@antiquelimited.com Dhirendra Tiwari +91 22 4031 3436 dhirendra.tiwari@antiquelimited.com

More information

April 20, 2015 Pressman Advertising Limited Good play in the growing advertising business

April 20, 2015 Pressman Advertising Limited Good play in the growing advertising business Good play in the growing advertising business April 20, 2015 Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 Company Report Recommendation CMP (Rs.) Target Price

More information

Ratio Analysis 0.75. Fixed Assets Fixed Assets + Net Working Capital =0.75 Fixed Assets

Ratio Analysis 0.75. Fixed Assets Fixed Assets + Net Working Capital =0.75 Fixed Assets Ratio Analysis CA Past Years Exam Answer Answer to Q.1: (Nov, 009) Fixed assets ` 18,00,000 Proprietor s funds ` 4,00,000 Note: 1 Ratio of fixed assets to proprietor s funds 0.75 Properietors Fund 0.75

More information

How To Understand And Value Gsk Pharma

How To Understand And Value Gsk Pharma 2QFY2016 Result Update Pharmaceutical November 2, 2015 GlaxoSmithKline Pharma Performance Highlights Y/E Mar (` cr) 2QFY2016 1QFY2016 % chg (qoq) 2QFY2015 % chg (yoy) Net Sales 692 622 11.3 739 (6.4) Other

More information

Tata Motors Ltd. Buy. New launches at domestic business as well as JLR to drive growth. February 12, 2016

Tata Motors Ltd. Buy. New launches at domestic business as well as JLR to drive growth. February 12, 2016 February 12, 2016 Buy Tata Motors Industry: Auto and Auto Components Industry View: Positive l Result Update New launches at domestic business as well as JLR to drive growth JLR margins in line, standalone

More information

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015

HEG Ltd (HEG) 160. Performs well. Result Update. ICICI Securities Ltd Retail Equity Research. November 10, 2015 Result Update Rating matrix Rating : Hold Target : 175 Target Period : 12 months Potential Upside : 9% What s Changed? Target Changed from 185 to 175 EPS FY16E Unchanged from 9.1 to 9.5 EPS FY17E Unchanged

More information

Cipla Ltd. INR 542. India Equity Institutional Research Pharma. Muted quarter; outlook remains robust. Target Price (INR): 646. Potential Upside : 19%

Cipla Ltd. INR 542. India Equity Institutional Research Pharma. Muted quarter; outlook remains robust. Target Price (INR): 646. Potential Upside : 19% India Equity Institutional Research Pharma RESULT UPDATE Cipla Ltd. INR 542 Muted quarter; outlook remains robust BUY Result highlights Cipla s Q3FY16 Net Sales, EBITDA and PAT were below our estimates.

More information